Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Commonwealth Biotechnologies Receives Marketplace Rule 4310(c)(14) Notice from NASDAQ
Nov 25, 2008 02:33 PM
- Commonwealth Biotechnologies, Inc. Asian Expansion
Sep 25, 2008 03:37 PM
- Commonwealth Biotechnologies Identified as Key Lab in the Amerithrax Investigation
Sep 22, 2008 10:03 AM
- ZyGEM and Commonwealth Biotechnologies Announce Research Collaboration for DNA Extraction Products
Sep 04, 2008 07:45 AM
- Commonwealth Biotechnologies, Inc. Reports Progress on its new Laboratories in China
Sep 03, 2008 12:47 PM
- Commonwealth Biotechnologies Reports Second Quarter 2008 Financial Results
Aug 15, 2008 04:12 PM
- Commonwealth Biotechnologies, Inc. Exercises $1 Million Put Option with Venturepharm Laboratories, Ltd.
Jul 09, 2008 11:49 AM
- Commonwealth Biotechnologies Expands Presence into Japan with Opening of Tokyo Office
Jun 17, 2008 01:14 PM
- Customer Service and Innovative Design the Keys to Success in Outsourcing Drug Development to China, Says Chairman of Commonwealth Biotechnologies, Inc.
Jun 05, 2008 02:10 PM
- Innovative Science and Reliable Project Management as Important as Low Cost in Selecting a Drug Discovery CRO, Says Commonwealth Biotechnologies CEO
Jun 02, 2008 08:21 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
CBTE
|
Compare to S&P
|
| YTD |
-84.32 %
|
-74.31 %
|
| 4 Weeks |
14.26 %
|
23.50 %
|
| 12 Weeks |
-45.96 %
|
-25.09 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 25.00 %
|
|
EPS Growth in Last Year: 6.25 %
|
|
Sales Growth in Last Quarter: -2.76 %
|
|
Sales Growth in Last Quarter: 14.40 %
|
|
|
